HIV 101: Fundamentals of HIV Pathogenesis, Initiation of Antiretroviral Therapy, and Primary Care for People With HIV

Assessment of Needs

This webinar is designed for clinicians caring for people with HIV, including residents, infectious diseases fellows, advanced practitioners, and practitioners in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs who are new to the field of HIV patient care. It is also relevant for clinicians who are interested in a review of the field. In the webinar, experts in the field will describe the core principles of HIV management, including pathogenesis of HIV infection, mechanism of action of antiretroviral drugs, initiating antiretroviral therapy, and primary care for people with HIV.

Learning Objectives

On completion of this webinar, learners will be able to describe:

• Events of early HIV infection
• Laboratory markers following HIV acquisition
• Basic mechanisms of antiretroviral therapy
• Antiretroviral regimens based on patient parameters
• Appropriate vaccinations for adults with HIV, focusing on hepatitis B, pneumococcus, and SARS CoV-2
• Appropriate cancer screening for people with HIV, focusing on cervical and anal cancer
• Screening for cardiovascular disease and managing hyperlipidemia in persons with HIV
• Screening for polypharmacy and frailty in persons with HIV

Registration

Who Should Attend

This webinar is designed for clinical decision makers who are in training, new to, or are interested in a review of HIV patient care, including physicians, physician assistants, nursing professionals, pharmacists, and other health care professionals.

Though attendance for the 2021 Ryan White HIV/AIDS CLINICAL CONFERENCE is limited to HIV physicians, nurse practitioners, physician assistants, and primary clinical decision makers in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs, registration for this webinar is open to all.

Individual registration is required in order to receive CME credit or a certificate of participation.

Registration closes on Tuesday, September 28, 2021, 10:00 AM (PT).

Certificates will be available after the completion of the evaluation and claim form.

For more information or questions, please contact the registration department at registration@iasusa.org or 415-544-9400.

Conflicts of Interest

In the interest of maintaining the independence of its continuing medical education (CME) activities, the International Antiviral Society–USA (IAS–USA) requires all persons with control of educational content (eg, faculty, Scientific Leadership Board, Governance Board, and program planner) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved and mitigated prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in IAS–USA CME activities.  

The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” 

IAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenter and planners/reviewers is below and in the slides prior to the presentation of educational content.

Planner/Reviewer

Planner/Reviewer 1 has no relevant financial relationships with ineligible companies to disclose. (Updated 09/28/21)
Planner/Reviewer 2 has no relevant financial relationships with ineligible companies to disclose. (Updated 09/28/21)

All relevant financial relationships have been mitigated.